<DOC>
	<DOCNO>NCT00397605</DOCNO>
	<brief_summary>Some people bipolar disorder use cannabis ( marijuana ) claim ease symptom depression mania . There many chemical ( call cannabinoids ) find cannabis two particular one appear medicinal ( therapeutic ) effect . These two compound : delta-9-tetrahydrocannabinol ( THC ) cannabidiol ( CBD ) . These cannabinoids appear mood , anxiety , sedative effect well antipsychotic anticonvulsant property . This study try find cannabinoids benefit add-on treatment bipolar disorder effect think power memory .</brief_summary>
	<brief_title>Cannabinoids Bipolar Affective Disorder</brief_title>
	<detailed_description>This study within-subject , random order , double-blind cross-over study standard clinical neuropsychological rating . Duration 13 week per subject . Clinical assessment include mood rating perform weekly . Instructions practice use spray give supervision 2-week run-in period baseline . Patients control dosage cannabinoids accord symptom administer maximum 48 pump-controlled spray per day . Patients ask abstain use cannabis ( study drug ) study . Patients treat 4 week either sublingual THC : CBD spray placebo spray . This follow 2-week washout period another 4 week treatment whichever study medication initially use . Neurocognitive testing perform 3 time study . A mood diary complete daily patient home .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Genetic Diseases , X-Linked</mesh_term>
	<criteria>Outpatients 1960 year age diagnosis bipolar disorder . Women must currently pregnant must use reliable method contraception duration study . Subjects must stable medication ( 4 week minimum ) bipolar illness ( symptomatic despite current treatment ) , must able provide write informed consent , must adequately understand write verbal English . Those meeting inclusion criterion able give inform consent . Women currently pregnant nursing . Those immediate risk harm self others ; clinically significant medical illness significant psychiatric illness ; currently abuse alcohol drug ; currently treat investigational medication medication contraindicate cannabinoids ; know allergy cannabisbased product .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>bipolar</keyword>
	<keyword>therapeutic potential</keyword>
	<keyword>neurocognitive performance</keyword>
	<keyword>cannabinoids</keyword>
</DOC>